US Stock MarketDetailed Quotes

Krystal Biotech (KRYS)

Watchlist

306.290
-10.010-3.16%

Close May 15 16:00 ET

305.000
-1.290-0.42%

Post 20:01 ET

9.03BMarket Cap41.00P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Krystal Biotech (KRYS) Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q1)Mar 31, 2026

(FY)Dec 31, 2025

(Q4)Dec 31, 2025

(Q3)Sep 30, 2025

(Q2)Jun 30, 2025

(Q1)Mar 31, 2025

(FY)Dec 31, 2024

(Q4)Dec 31, 2024

(Q3)Sep 30, 2024

(Q2)Jun 30, 2024

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

159.56%80.38M

62.75%200.87M

46.68%77.51M

-32.62%39.66M

1,365.09%52.73M

94.92%30.97M

238.98%123.42M

830.68%52.84M

377.29%58.86M

87.81%-4.17M

Net income from continuing operations

56.53%55.93M

129.74%204.83M

13.02%51.4M

192.00%79.36M

146.22%38.33M

3,734.01%35.73M

715.58%89.16M

423.23%45.48M

-66.34%27.18M

146.88%15.57M

Operating gains losses

64.78%-529K

1.91%-5.95M

75.40%-404K

17.54%-1.29M

-67.31%-2.75M

-23.83%-1.5M

94.23%-6.07M

-36.15%-1.64M

98.46%-1.57M

-4.11%-1.65M

Depreciation and amortization

5.63%1.73M

-2.43%6.55M

13.31%1.76M

5.43%1.61M

-23.65%1.54M

1.55%1.63M

13.58%6.71M

-11.50%1.56M

12.01%1.53M

36.74%2.02M

Deferred tax

----

---22.85M

--1.84M

----

--0

----

Other non cash items

-77.85%136K

4.91%684K

495.89%289K

-146.38%-295K

-76.76%76K

357.98%614K

200.46%652K

-124.83%-73K

600.79%636K

567.35%327K

Change In working capital

154.41%10.08M

-151.91%-36.42M

267.80%9.5M

-253.20%-27.88M

101.48%494K

-394.16%-18.54M

62.47%-14.46M

78.25%-5.66M

291.78%18.2M

-181.74%-33.29M

-Change in receivables

-96.10%58K

64.72%-22.12M

133.45%2.49M

-401.78%-17.92M

85.59%-8.18M

133.57%1.49M

-49.16%-62.71M

77.24%-7.45M

163.75%5.94M

---56.77M

-Change in inventory

82.58%-243K

47.21%-6.29M

83.78%-1.06M

-28.14%-4.71M

66.04%880K

37.67%-1.4M

-166.08%-11.91M

-1,225.41%-6.52M

-19.53%-3.68M

158.50%530K

-Change in prepaid assets

155.98%1.67M

-64.54%-14.66M

96.10%-245K

-9,290.98%-11.46M

100.83%19K

-1,303.77%-2.98M

-452.67%-8.91M

-447.39%-6.28M

-165.95%-122K

-338.05%-2.29M

-Change in payables and accrued expense

146.08%7.4M

-92.77%4.95M

-44.08%7.91M

-62.59%6.02M

-71.59%7.06M

-219.97%-16.05M

556.31%68.48M

66.13%14.15M

419.03%16.1M

340.64%24.86M

-Change in other current assets

----

88.61%-18K

-114.74%-23K

-Change in other current liabilities

203.52%1.21M

190.44%1.7M

-10.18%397K

613.16%195K

86.88%712K

300.00%398K

170.69%586K

295.58%442K

82.96%-38K

277.21%381K

Cash from discontinued investing activities

Operating cash flow

159.56%80.38M

62.75%200.87M

46.68%77.51M

-32.62%39.66M

1,365.09%52.73M

94.92%30.97M

238.98%123.42M

830.68%52.84M

377.29%58.86M

87.81%-4.17M

Investing cash flow

Cash flow from continuing investing activities

-16.09%-63.58M

64.26%-58.42M

113.32%11.16M

87.51%-4.29M

45.62%-10.53M

-110.81%-54.77M

-297.78%-163.44M

-724.59%-83.78M

-132.63%-34.33M

-21.28%-19.35M

Net PPE purchase and sale

-15.22%-7.15M

-182.00%-11.95M

-167.04%-2.14M

-62.91%-1.7M

-68.35%-1.9M

-392.38%-6.2M

64.08%-4.24M

56.63%-801K

41.27%-1.05M

59.46%-1.13M

Net investment purchase and sale

-15.17%-56.44M

70.54%-46.9M

116.03%13.3M

92.24%-2.58M

52.69%-8.62M

-98.22%-49M

-2,761.78%-159.2M

-898.16%-82.98M

-577.30%-33.28M

-38.39%-18.22M

Net other investing changes

----

--435K

--0

--435K

----

Cash from discontinued investing activities

Investing cash flow

-16.09%-63.58M

64.26%-58.42M

113.32%11.16M

87.51%-4.29M

45.62%-10.53M

-110.81%-54.77M

-297.78%-163.44M

-724.59%-83.78M

-132.63%-34.33M

-21.28%-19.35M

Financing cash flow

Cash flow from continuing financing activities

16.10%-10.46M

-67.78%8.71M

545.22%15.67M

10.22%3.71M

-83.12%1.8M

-217.79%-12.47M

-86.68%27.01M

-7.29%2.43M

-74.87%3.37M

-94.26%10.64M

Net common stock issuance

----

--0

----

--0

----

Proceeds from stock option exercised by employees

344.66%6.5M

-30.06%22.66M

546.17%15.69M

10.37%3.71M

-83.12%1.8M

-90.84%1.46M

-25.98%32.4M

-6.94%2.43M

-75.09%3.37M

-58.17%10.64M

Net other financing activities

-21.77%-16.96M

-159.12%-13.96M

---23K

---5K

--0

-158.60%-13.93M

-619.09%-5.39M

--0

Cash from discontinued financing activities

Financing cash flow

16.10%-10.46M

-67.78%8.71M

545.22%15.67M

10.22%3.71M

-83.12%1.8M

-217.79%-12.47M

-86.68%27.01M

-7.29%2.43M

-74.87%3.37M

-94.26%10.64M

Net cash flow

Beginning cash position

43.91%496.3M

-3.76%344.87M

4.98%392.6M

2.33%353.83M

-13.99%308.77M

-3.76%344.87M

121.33%358.33M

0.19%373.97M

25.34%345.79M

155.08%359.01M

Current changes in cash

117.48%6.34M

1,262.27%151.15M

466.00%104.34M

40.11%39.08M

441.54%44M

-7,486.15%-36.27M

-106.62%-13.01M

-92.97%-28.51M

-71.35%27.89M

-109.53%-12.88M

Effect of exchange rate changes

-878.36%-1.33M

162.45%286K

-7.24%-637K

-207.34%-307K

414.24%1.06M

-8.56%171K

-193.59%-458K

-324.29%-594K

2,283.33%286K

-4,312.50%-337K

End cash Position

62.36%501.31M

43.91%496.3M

4.98%392.6M

2.33%353.83M

-13.99%308.77M

-3.76%344.87M

0.19%373.97M

25.34%345.79M

Free cash flow

195.72%73.23M

58.51%188.91M

44.82%75.37M

-34.35%37.96M

1,059.14%50.83M

69.30%24.77M

218.47%119.18M

673.21%52.04M

351.28%57.81M

85.67%-5.3M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q1)Mar 31, 2026	(FY)Dec 31, 2025	(Q4)Dec 31, 2025	(Q3)Sep 30, 2025	(Q2)Jun 30, 2025	(Q1)Mar 31, 2025	(FY)Dec 31, 2024	(Q4)Dec 31, 2024	(Q3)Sep 30, 2024	(Q2)Jun 30, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	159.56%80.38M	62.75%200.87M	46.68%77.51M	-32.62%39.66M	1,365.09%52.73M	94.92%30.97M	238.98%123.42M	830.68%52.84M	377.29%58.86M	87.81%-4.17M
Net income from continuing operations	56.53%55.93M	129.74%204.83M	13.02%51.4M	192.00%79.36M	146.22%38.33M	3,734.01%35.73M	715.58%89.16M	423.23%45.48M	-66.34%27.18M	146.88%15.57M
Operating gains losses	64.78%-529K	1.91%-5.95M	75.40%-404K	17.54%-1.29M	-67.31%-2.75M	-23.83%-1.5M	94.23%-6.07M	-36.15%-1.64M	98.46%-1.57M	-4.11%-1.65M
Depreciation and amortization	5.63%1.73M	-2.43%6.55M	13.31%1.76M	5.43%1.61M	-23.65%1.54M	1.55%1.63M	13.58%6.71M	-11.50%1.56M	12.01%1.53M	36.74%2.02M
Deferred tax	----	---22.85M	--1.84M	----	----	----	--0	--0	----	----
Other non cash items	-77.85%136K	4.91%684K	495.89%289K	-146.38%-295K	-76.76%76K	357.98%614K	200.46%652K	-124.83%-73K	600.79%636K	567.35%327K
Change In working capital	154.41%10.08M	-151.91%-36.42M	267.80%9.5M	-253.20%-27.88M	101.48%494K	-394.16%-18.54M	62.47%-14.46M	78.25%-5.66M	291.78%18.2M	-181.74%-33.29M
-Change in receivables	-96.10%58K	64.72%-22.12M	133.45%2.49M	-401.78%-17.92M	85.59%-8.18M	133.57%1.49M	-49.16%-62.71M	77.24%-7.45M	163.75%5.94M	---56.77M
-Change in inventory	82.58%-243K	47.21%-6.29M	83.78%-1.06M	-28.14%-4.71M	66.04%880K	37.67%-1.4M	-166.08%-11.91M	-1,225.41%-6.52M	-19.53%-3.68M	158.50%530K
-Change in prepaid assets	155.98%1.67M	-64.54%-14.66M	96.10%-245K	-9,290.98%-11.46M	100.83%19K	-1,303.77%-2.98M	-452.67%-8.91M	-447.39%-6.28M	-165.95%-122K	-338.05%-2.29M
-Change in payables and accrued expense	146.08%7.4M	-92.77%4.95M	-44.08%7.91M	-62.59%6.02M	-71.59%7.06M	-219.97%-16.05M	556.31%68.48M	66.13%14.15M	419.03%16.1M	340.64%24.86M
-Change in other current assets	----	----	----	----	----	----	----	----	88.61%-18K	-114.74%-23K
-Change in other current liabilities	203.52%1.21M	190.44%1.7M	-10.18%397K	613.16%195K	86.88%712K	300.00%398K	170.69%586K	295.58%442K	82.96%-38K	277.21%381K
Cash from discontinued investing activities
Operating cash flow	159.56%80.38M	62.75%200.87M	46.68%77.51M	-32.62%39.66M	1,365.09%52.73M	94.92%30.97M	238.98%123.42M	830.68%52.84M	377.29%58.86M	87.81%-4.17M
Investing cash flow
Cash flow from continuing investing activities	-16.09%-63.58M	64.26%-58.42M	113.32%11.16M	87.51%-4.29M	45.62%-10.53M	-110.81%-54.77M	-297.78%-163.44M	-724.59%-83.78M	-132.63%-34.33M	-21.28%-19.35M
Net PPE purchase and sale	-15.22%-7.15M	-182.00%-11.95M	-167.04%-2.14M	-62.91%-1.7M	-68.35%-1.9M	-392.38%-6.2M	64.08%-4.24M	56.63%-801K	41.27%-1.05M	59.46%-1.13M
Net investment purchase and sale	-15.17%-56.44M	70.54%-46.9M	116.03%13.3M	92.24%-2.58M	52.69%-8.62M	-98.22%-49M	-2,761.78%-159.2M	-898.16%-82.98M	-577.30%-33.28M	-38.39%-18.22M
Net other investing changes	----	--435K	--0	--0	--0	--435K	----	----	----	----
Cash from discontinued investing activities
Investing cash flow	-16.09%-63.58M	64.26%-58.42M	113.32%11.16M	87.51%-4.29M	45.62%-10.53M	-110.81%-54.77M	-297.78%-163.44M	-724.59%-83.78M	-132.63%-34.33M	-21.28%-19.35M
Financing cash flow
Cash flow from continuing financing activities	16.10%-10.46M	-67.78%8.71M	545.22%15.67M	10.22%3.71M	-83.12%1.8M	-217.79%-12.47M	-86.68%27.01M	-7.29%2.43M	-74.87%3.37M	-94.26%10.64M
Net common stock issuance	----	--0	----	----	----	----	--0	--0	--0	----
Proceeds from stock option exercised by employees	344.66%6.5M	-30.06%22.66M	546.17%15.69M	10.37%3.71M	-83.12%1.8M	-90.84%1.46M	-25.98%32.4M	-6.94%2.43M	-75.09%3.37M	-58.17%10.64M
Net other financing activities	-21.77%-16.96M	-159.12%-13.96M	---23K	---5K	--0	-158.60%-13.93M	-619.09%-5.39M	--0	--0	--0
Cash from discontinued financing activities
Financing cash flow	16.10%-10.46M	-67.78%8.71M	545.22%15.67M	10.22%3.71M	-83.12%1.8M	-217.79%-12.47M	-86.68%27.01M	-7.29%2.43M	-74.87%3.37M	-94.26%10.64M
Net cash flow
Beginning cash position	43.91%496.3M	-3.76%344.87M	4.98%392.6M	2.33%353.83M	-13.99%308.77M	-3.76%344.87M	121.33%358.33M	0.19%373.97M	25.34%345.79M	155.08%359.01M
Current changes in cash	117.48%6.34M	1,262.27%151.15M	466.00%104.34M	40.11%39.08M	441.54%44M	-7,486.15%-36.27M	-106.62%-13.01M	-92.97%-28.51M	-71.35%27.89M	-109.53%-12.88M
Effect of exchange rate changes	-878.36%-1.33M	162.45%286K	-7.24%-637K	-207.34%-307K	414.24%1.06M	-8.56%171K	-193.59%-458K	-324.29%-594K	2,283.33%286K	-4,312.50%-337K
End cash Position	62.36%501.31M	43.91%496.3M	43.91%496.3M	4.98%392.6M	2.33%353.83M	-13.99%308.77M	-3.76%344.87M	-3.76%344.87M	0.19%373.97M	25.34%345.79M
Free cash flow	195.72%73.23M	58.51%188.91M	44.82%75.37M	-34.35%37.96M	1,059.14%50.83M	69.30%24.77M	218.47%119.18M	673.21%52.04M	351.28%57.81M	85.67%-5.3M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--	--	--

No. Symbol 5D % Chg

Middle East conflict spreads to the stock market! How should investors respond?

According to Axios, on Sunday local time, Trump rejected Iran's latest ceasefire proposal, prompting a sharp response from Iran: no one woul Show More

牛牛課堂

Mar 4 17:09

Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.

牛牛課堂

Mar 18 18:18

Hormuz, Term Structure and USO: Navigating the Energy Storm